Johns Hopkins School of Medicine
Baltimore, Maryland, 21287, United States
Location status: Recruiting
Location contact
Heidi Hutton
CONTACT
Heidi Hutton, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05163301
3-arm type 1 pilot implementation-efficacy trial for people with alcohol use disorders to examine the preliminary effectiveness and feasibility of an adapted 2-session, computerized and person delivered relapse prevention intervention.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Baltimore, Maryland, 21287, United States
Location status: Recruiting
Heidi Hutton
CONTACT
Heidi Hutton, PhD
PRINCIPAL_INVESTIGATOR
This study will develop a brief counseling intervention for people with HIV who have resumed alcohol use or resumed hazardous alcohol use after a minimum of 3 years of alcohol abstinence or 'lower risk' alcohol use. The investigators will develop a 2session person delivered and a 2-session computer delivered intervention which the investigators will then compare with the usual treatment for alcohol counseling offered at the HIV clinic. The investigators will also study the acceptability and feasibility of implementing both types of counseling in the clinic.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
In addition, meet the following alcohol use criteria:
Exclusion criteria
2 session intervention to address relapse prevention among people with HIV who have an alcohol use disorder
Time frame: 6 and 12 months
Time to return to any alcohol use or any at risk alcohol use after intervention.
Time frame: Baseline, 6 and 12 months
Number of drinking days.
Time frame: Baseline, 6 and 12 months
Number of heavy drinking days.
Time frame: Baseline, 6 and 12 months
Number of drinks per drinking day.
Time frame: Baseline, 6 and 12 months
Number of days abstinent.
Contact information is provided by the study sponsor or research team.
Johns Hopkins University
Other
Alcohol Research Consortium in HIV: Relapse Prevention Arm
Acronym: ARCH-RPA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06790342
Alcohol Use Disorder, Alcohol-Related Disorders
Nairobi, Kenya
View Trial DetailsNCT06004830
Acquired Immunodeficiency Syndrome, Alcohol Use Disorder
Decatur, Georgia, United States
View Trial DetailsNCT06006143
Acquired Immunodeficiency Syndrome, Alcohol Use Disorder
Decatur, Georgia, United States
View Trial DetailsNCT02060162
Africa, Alcohol Use Disorder
Lusaka, Zambia
View Trial Details